Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Chief Executive Officer

Hillstream BioPharma, Inc., a pre-clinical biotechnology company, develops novel therapeutic candidates targeting ferroptosis, an anti-cancer mechanism resulting in iron mediated cell death (IMCD) and targeted immuno-oncology novel biologics for the treatment drug resistant cancers. The company's product candidate is HSB-1216, an IMCD inducer targeting solid tumors. It also develops HSB-3215, an anti-HER2 monoclonal antibody candidate; and HSB-1940, a Quatrabody that is a proprietary IO biologic in development targeting PD-1. The company was incorporated in 2017 and is based in Bridgewater, New Jersey.

Hillstream BioPharma, Inc., a pre-clinical biotechnology company, develops novel therapeutic candidates targeting ferroptosis, an anti-can...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2022-07-14	Premium	gifted	Premium	Premium	Premium	-
2022-07-14	Premium	gifted	Premium	Premium	Premium	-
2022-06-17	Premium	bought	Premium	Premium	Premium	Chief Executive Officer
2022-06-06	Premium	bought	Premium	Premium	Premium	Chief Executive Officer
2022-06-01	Premium	bought	Premium	Premium	Premium	Chief Executive Officer
2022-05-25	Premium	bought	Premium	Premium	Premium	Chief Executive Officer
2022-05-20	Premium	bought	Premium	Premium	Premium	Chief Executive Officer
2022-05-19	Premium	bought	Premium	Premium	Premium	Chief Executive Officer
2022-04-18	Premium	acquired	Premium	Premium	Premium	Chief Executive Officer
2022-01-14	Premium	acquired	Premium	Premium	Premium	Chief Executive Officer
2022-01-14	Premium	acquired	Premium	Premium	Premium	Chief Executive Officer
2022-01-14	Premium	acquired	Premium	Premium	Premium	Chief Executive Officer
2022-01-14	Premium	bought	Premium	Premium	Premium	-
2022-01-14	Premium	acquired	Premium	Premium	Premium	-

HILS - Hillstream BioPharma, Inc. Stock Price, Fair Value and News

Latest Insider Trading transactions for HILS